Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: A randomized, double-masked, placebo- controlled, dose-response, multicenter study

Pediatrics

Volumn 101, Issue 3 I, 1998, Pages 325-334

  Davidson, Dennis ^a,f   Barefield, Elaine S ^a,b   Kattwinkel, John ^a,c   Dudell, Golde ^a,d   Damask, Michael ^e   Straube, Richard ^e   Rhines, Jared ^e   Chang, Cheng Tao ^e  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d RADY CHILDREN'S HOSPITAL   (United States)

^e PPD   (United States)

^f SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

Bronchopulmonary dysplasia; Extracorporeal membrane oxygenation; Methemoglobinemia; Neonatal outcome; Nitrogen dioxide

Indexed keywords

NITRIC OXIDE;

AIRWAY PRESSURE; ARTERIAL PRESSURE; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OXYGENATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYDROGEN-ION CONCENTRATION; INFANT, NEWBORN; MALE; METHEMOGLOBINEMIA; NITRIC OXIDE; NITROGEN DIOXIDE; OXYGEN; PERSISTENT FETAL CIRCULATION SYNDROME; TREATMENT OUTCOME;

EID: 0031929875     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.101.3.325     Document Type: Article

References (35)

1. Gersony WM, Duc GV, Sinclair JC. 'PFC' Syndrome (Persistence of the fetal circulation). Circulation. 1969;40(suppl 3):87. Abstract
2. Morin FC III, Stenmark KR. Persistent pulmonary hypertension of the newborn: state of the art. Am J Resp Crit Car Med. 1995;151:2010-2032
3. Linde-Zwirble WT, Angus DC, Clermont G, Roberts MS, et al. Diagnoses associated with the delivery of mechanical ventilation in the newborn. Pediatr Res. 1997;41:202A
4. Walsh-Sukys M, Fanaroff A, Wright L, et al. Persistent pulmonary hypertension of the newborn (PPHN): prospective, multicenter study of treatments and outcome. Pediatr Res. 1995;37:244A
5. Weigel TJ, Hageman JR. National survey of diagnosis and management of persistent pulmonary hypertension of the newborn. J Perinatol. 1990; 10:369-375
6. Kanto WP Jr. A decade of experience with neonatal extracorporeal membrane oxygenation. J Pediatr. 1994;124:335-347
7. Shanley CJ, Hirschl RB, Schumacher RE, et al. Extracorporeal life support for neonatal respiratory failure - a 20-year experience. Ann Surg. 1994;220:269-281
8. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992;340: 818-819
9. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992;340:819-820
10. Dobyns EL, Westcott JY, Kennaugh JM, Ross MN, Stenmark KR. Eicosanoids decrease with successful extracorporeal membrane oxygenation therapy in neonatal pulmonary hypertension. Am J Respir Crit Care Med. 1994;149:873-880
11. Davis JM, Whitin J. Prophylactic effects of dexamethasone in lung injury caused by hyperoxia and hyperventilation. J Appl Physiol. 1992;72: 1320-1325
12. Roberts JD, Chen TY, Kawai N, et al. Inhaled nitric oxide reverse pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ Res. 1993;72:246-254
13. Kinsella JP, Neish SR, Ivy DD, Shafer E, Abman SH. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr. 1993;123: 103-108
14. Finer NN, Etches PC, Kamstra B, Tierney AJ, Peliowski A, Ryan CA. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr. 1994;124:302-308
15. Rozé JC, Storme L, Zupan V, Morville P, Dinh-Xuan AT, Mercier JC. Echocardiographic investigation of inhaled nitric oxide in newborns with severe hypoxemia. Lancet. 1994;344:303-305
16. Davidson D. NO bandwagon, yet: Inhaled nitric oxide (NO) for neonatal pulmonary hypertension. Am Rev Respir Dis. 1993;147:1078-1079
17. Bathe D, Berssenbrugge A, Montgomery F. Monitoring accuracy for the measurement of nitric oxide in the 0 to 80 ppm range. Crit Care Med. 1996;24:A103
18. Sokol GM, Van Meurs KP, Thorn WJ, et al. Limitations in nitrogen dioxide measurement with commercially available analyzers. Presented at the Twelfth Annual Children's National Medical Center Symposium on ECMO and Advanced Therapies for Respiratory Failure; Keystone, CO. (Abstract #71). 1996
19. Centers for Disease Control. Recommendations for occupational safety and health standards. MMWR. 1988;37(suppl):21
20. US Department of Health and Human Services. COSTART. Coding symbols for thesaurus of adverse events. FDA Office of Epidemiology and Biostatistics. 3rd ed. Washington, DC: US Department of Health and Human Services; 1989
21. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med. 1997;336:597-604
22. Lotze A and The Survanta in Term Infants Study Group. Survanta pre-ECMO trial: multicenter evaluation of Survanta in treatment of term infants with severe respiratory failure. Pediatr Res. 1996;39:226A
23. Findlay RD, Taeusch HW, Walther FJ. Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics. 1996;97:48-52
24. Clark RH, Yoder BA, Sell MS. Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. J Pediatr. 1994;124:447-454
25. Kinsella JP, Truog WE, Walsh WF, et al. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr. 1997;131:55-62
26. Wiswell TE, Graziani LJ, Kornhauser MS, et al. High-frequency jet ventilation in the early management of respiratory distress syndrome is associated with a greater risk of adverse outcomes. Pediatrics. 1996;98: 1035-1043
27. Stark AR, Davidson D. Inhaled nitric oxide for persistent pulmonary hypertension of the newborn: implications and strategy for future "high-tech" neonatal clinical trials. Pediatrics. 1995;96:1147-1151
28. UK Collaborative ECMO Trial Group. UK collaborative randomized trial of neonatal extracorporeal membrane oxygenation. Lancet. 1996; 348:75-82
29. Roberts JD, Fineman JR, Morin FC III, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med. 1997;336:605-610
30. Högrnan M, Frostell C, Arnberg H, Hedenstierna G. Bleeding time prolongation and NO inhalation. Lancet. 1993;341:1664-1665
31. Freeman B. Free radical chemistry of nitric oxide. Chest. 1994;105:79S-83S
32. Wessel DL, Adiatia I, Thompson JE, Hickey PR. Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit Care Med. 1994;22:930-938
33. Foubert L, Fleming B, Latimer R, et al. Safety guidelines for use of nitric oxide. Lancet. 1992;339:1615-1616
34. Miller OI, Tang SF, Keech A, Celermajer DS. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide. Lancet. 1995;346: 51-52
35. Aly H, Sahni R, Wong JT. Weaning strategy with inhaled nitric oxide treatment in persistent pulmonary hypertension of the newborn. Arch Dis Child. 1997;76:F118-F122